Optimizing G6PD testing for Plasmodium vivax case management and beyond: why sex, counseling, and community engagement matter
Safe access to the most effective treatment options for Plasmodium vivax malaria are limited by the absence of accurate point-of-care testing to detect glucose-6-phosphate dehydrogenase (G6PD) deficiency, the most common human genetic disorder. G6PD-deficient patients are at risk of life-threatenin...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388194/ https://www.ncbi.nlm.nih.gov/pubmed/32766454 http://dx.doi.org/10.12688/wellcomeopenres.15700.2 |